Event Type: Earnings conference call for Q1 FY26-27 results
Event Date: August 14, 2026 (call already held)
Purpose: Discussion of quarterly financial results for Q1 FY26-27
Regulatory Reference: Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Management Participants: Not specified in this disclosure
Audio Availability: Complete audio recording of the earnings call is available on the company's website at https://admin.natcopharma.co.in/wp-content/uploads/2026/08/Q1FY27.mp3
UPSI Statement: The disclosure does not contain any specific statement regarding unpublished price sensitive information
Additional Notes Section
Attachments: No attachments mentioned in this specific disclosure
Financial Data Disclosure: This announcement does not contain any financial figures or performance metrics - it solely provides access to the earnings call audio recording
Submitted By: Ch. Venkat Ramesh, Company Secretary & Compliance Officer
Recipients: BSE Limited and National Stock Exchange of India Limited
